• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SMN2基因第7外显子中的一个负性元件会抑制脊髓性肌萎缩症中的剪接过程。

A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy.

作者信息

Kashima Tsuyoshi, Manley James L

机构信息

Department of Biological Sciences, Columbia University, New York, New York 10027, USA.

出版信息

Nat Genet. 2003 Aug;34(4):460-3. doi: 10.1038/ng1207.

DOI:10.1038/ng1207
PMID:12833158
Abstract

Spinal muscular atrophy (SMA) is a relatively common neurodegenerative disease caused by homozygous loss of the survival motor neuron 1 (SMN1) gene. Humans possess a linked, nearly identical gene, SMN2, which produces a functional SMN protein but at levels insufficient to compensate for loss of SMN1 (refs. 1,2). A C/T transition at position +6 in exon 7 is all that differentiates the two genes, but this is sufficient to prevent efficient exon 7 splicing in SMN2 (refs. 2,3). Here we show that the C/T transition functions not to disrupt an exonic splicing enhancer (ESE) in SMN1 (ref. 4), as previously suggested, but rather to create an exonic splicing silencer (ESS) in SMN2. We show that this ESS functions as a binding site for a known repressor protein, hnRNP A1, which binds to SMN2 but not SMN1 exon 7 RNA. We establish the physiological importance of these results by using small interfering RNAs to reduce hnRNP A protein levels in living cells and show that this results in efficient SMN2 exon 7 splicing. Our findings not only define a new mechanism underlying the inefficient splicing of SMN2 exon 7 but also illustrate more generally the remarkable sensitivity and precision that characterizes control of mRNA splicing.

摘要

脊髓性肌萎缩症(SMA)是一种相对常见的神经退行性疾病,由生存运动神经元1(SMN1)基因的纯合缺失引起。人类拥有一个与之连锁且几乎相同的基因SMN2,它能产生功能性的SMN蛋白,但产生水平不足以弥补SMN1的缺失(参考文献1,2)。外显子7中第+6位的C/T转换是区分这两个基因的唯一差异,但这足以阻止SMN2中外显子7的有效剪接(参考文献2,3)。我们在此表明,C/T转换并非如先前推测的那样破坏SMN1中的外显子剪接增强子(ESE),而是在SMN2中产生一个外显子剪接沉默子(ESS)。我们发现这个ESS作为一种已知阻遏蛋白hnRNP A1的结合位点,hnRNP A1能与SMN2外显子7的RNA结合,但不与SMN1外显子7的RNA结合。我们通过使用小干扰RNA降低活细胞中hnRNP A蛋白水平,证实了这些结果的生理重要性,并表明这会导致SMN2外显子7的有效剪接。我们的发现不仅定义了SMN2外显子7剪接效率低下的一种新机制,还更普遍地说明了mRNA剪接控制所具有的显著敏感性和精确性。

相似文献

1
A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy.SMN2基因第7外显子中的一个负性元件会抑制脊髓性肌萎缩症中的剪接过程。
Nat Genet. 2003 Aug;34(4):460-3. doi: 10.1038/ng1207.
2
An intronic element contributes to splicing repression in spinal muscular atrophy.一个内含子元件促成脊髓性肌萎缩症中的剪接抑制。
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3426-31. doi: 10.1073/pnas.0700343104. Epub 2007 Feb 16.
3
Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector.通过病毒载体递送双功能RNA来刺激全长SMN2的表达。
Mol Ther. 2006 Jul;14(1):54-62. doi: 10.1016/j.ymthe.2006.01.012. Epub 2006 Mar 31.
4
Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2.脊髓性肌萎缩症基因SMN1和SMN2中第7外显子剪接的决定因素。
Am J Hum Genet. 2006 Jan;78(1):63-77. doi: 10.1086/498853. Epub 2005 Nov 16.
5
Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1.SMN2中一个依赖于SF2/ASF的外显子剪接增强子的破坏在缺乏SMN1的情况下会导致脊髓性肌萎缩。
Nat Genet. 2002 Apr;30(4):377-84. doi: 10.1038/ng854. Epub 2002 Mar 4.
6
HnRNP C1/C2 may regulate exon 7 splicing in the spinal muscular atrophy gene SMN1.异质性核糖核蛋白C1/C2可能调控脊髓性肌萎缩症基因SMN1中外显子7的剪接。
Kobe J Med Sci. 2009 Mar 10;54(5):E227-36.
7
hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing.异质性核糖核蛋白A1在抑制SMN2基因第7外显子剪接过程中具有特异性作用。
Hum Mol Genet. 2007 Dec 15;16(24):3149-59. doi: 10.1093/hmg/ddm276. Epub 2007 Sep 19.
8
Spinal muscular atrophy: from gene to therapy.脊髓性肌萎缩症:从基因到治疗
Semin Pediatr Neurol. 2006 Jun;13(2):121-31. doi: 10.1016/j.spen.2006.06.008.
9
Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.新型2,4-二氨基喹唑啉衍生物作为SMN2启动子激活剂用于脊髓性肌萎缩症潜在治疗的合成与生物学评价
J Med Chem. 2008 Feb 14;51(3):449-69. doi: 10.1021/jm061475p. Epub 2008 Jan 19.
10
A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels.对运动神经元存活蛋白(SMN)蛋白活性的非序列特异性需求:氨基糖苷类药物在诱导SMN蛋白水平升高方面的作用
Hum Mol Genet. 2005 May 1;14(9):1199-210. doi: 10.1093/hmg/ddi131. Epub 2005 Mar 24.

引用本文的文献

1
Biological function of RNA-binding proteins in myocardial infarction: a potential emerging therapeutic limelight.RNA结合蛋白在心肌梗死中的生物学功能:一个潜在的新兴治疗焦点。
Cell Biosci. 2025 May 24;15(1):65. doi: 10.1186/s13578-025-01408-8.
2
Research trends on spinal muscular atrophy from 1995 to 2023: A bibliometric analysis.1995年至2023年脊髓性肌萎缩症的研究趋势:一项文献计量分析。
Medicine (Baltimore). 2025 Mar 28;104(13):e41801. doi: 10.1097/MD.0000000000041801.
3
Carrier Screening and Prenatal Diagnosis for Spinal Muscular Atrophy in Ningde City, Fujian Province.
福建省宁德市脊髓性肌萎缩症的携带者筛查与产前诊断
Mol Genet Genomic Med. 2025 Feb;13(2):e70077. doi: 10.1002/mgg3.70077.
4
High Expression of SMN circ4-2b-3 in SMA I Children Treated with Nusinersen is Associated with Improved Motor Outcomes.在接受诺西那生治疗的脊髓性肌萎缩症I型儿童中,SMN circ4-2b-3的高表达与运动功能改善相关。
Mol Neurobiol. 2025 May;62(5):5640-5649. doi: 10.1007/s12035-024-04605-7. Epub 2024 Nov 27.
5
Spinal Muscular Atrophy: Current Medications and Re-purposed Drugs.脊髓性肌萎缩症:现有药物和再利用药物。
Cell Mol Neurobiol. 2024 Nov 8;44(1):75. doi: 10.1007/s10571-024-01511-3.
6
Genetic Variability in Oxidative Stress, Inflammatory, and Neurodevelopmental Pathways: Impact on the Susceptibility and Course of Spinal Muscular Atrophy.氧化应激、炎症和神经发育途径中的遗传变异性:对脊髓性肌萎缩易感性和病程的影响。
Cell Mol Neurobiol. 2024 Oct 27;44(1):71. doi: 10.1007/s10571-024-01508-y.
7
A sequential binding mechanism for 5' splice site recognition and modulation for the human U1 snRNP.一种用于人类 U1 snRNP 的 5' 剪接位点识别和调节的连续结合机制。
Nat Commun. 2024 Oct 10;15(1):8776. doi: 10.1038/s41467-024-53124-5.
8
Spinal muscular atrophy caused by compound heterozygous SMN1 mutations: two cases and literature review.由复合杂合 SMN1 突变引起的脊髓性肌萎缩症:两例病例报告及文献复习。
Neurol Sci. 2024 Dec;45(12):5605-5615. doi: 10.1007/s10072-024-07651-0. Epub 2024 Jul 8.
9
Antisense Oligonucleotides (ASOs) in Motor Neuron Diseases: A Road to Cure in Light and Shade.反义寡核苷酸 (ASO) 在运动神经元疾病中的应用:光明与黑暗中的治愈之路。
Int J Mol Sci. 2024 Apr 28;25(9):4809. doi: 10.3390/ijms25094809.
10
A Sequential Binding Mechanism for 5' Splice Site Recognition and Modulation for the Human U1 snRNP.人源U1小核核糖核蛋白识别和调控5'剪接位点的顺序结合机制
bioRxiv. 2024 Apr 18:2024.04.18.590139. doi: 10.1101/2024.04.18.590139.